ADiTx Therapeutics Inc. [NASDAQ: ADTX] gained 11.89% on the last trading session, reaching $3.20 price per share at the time. The company report on May 3, 2021 that Aditxt to Establish State-of-the-Art Immune Monitoring Center in Richmond, VA.
AditxtScore™ Center is the first of a planned immune monitoring network and will initially monitor COVID-19 immunity status.
New facility expects to target more than 300 jobs over three years to the area.
ADiTx Therapeutics Inc. represents 12.34 million in outstanding shares, while the company has a total market value of $43.97 million with the latest information. ADTX stock price has been found in the range of $2.62 to $3.20.
If compared to the average trading volume of 901.92K shares, ADTX reached a trading volume of 3312609 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about ADiTx Therapeutics Inc. [ADTX]:
The Average True Range (ATR) for ADiTx Therapeutics Inc. is set at 0.25 The Price to Book ratio for the last quarter was 3.60, with the Price to Cash per share for the same quarter was set at 0.76.
Trading performance analysis for ADTX stock
ADiTx Therapeutics Inc. [ADTX] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 13.48. With this latest performance, ADTX shares gained by 22.61% in over the last four-week period, additionally plugging by 60.00% over the last 6 months.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ADTX stock in for the last two-week period is set at 60.66, with the RSI for the last a single of trading hit 69.52, and the three-weeks RSI is set at 56.03 for ADiTx Therapeutics Inc. [ADTX]. The present Moving Average for the last 50 days of trading for this stock 2.93, while it was recorded at 2.85 for the last single week of trading, and 2.83 for the last 200 days.
ADiTx Therapeutics Inc. [ADTX]: A deeper dive into fundamental analysis
Return on Total Capital for ADTX is now -185.34, given the latest momentum, and Return on Invested Capital for the company is -202.92. Return on Equity for this stock declined to -224.26, with Return on Assets sitting at -138.41. When it comes to the capital structure of this company, ADiTx Therapeutics Inc. [ADTX] has a Total Debt to Total Equity ratio set at 11.35. Additionally, ADTX Total Debt to Total Capital is recorded at 10.19, with Total Debt to Total Assets ending up at 9.54. Long-Term Debt to Equity for the company is recorded at 7.79, with the Long-Term Debt to Total Capital now at 7.00.
Reflecting on the efficiency of the workforce at the company, ADiTx Therapeutics Inc. [ADTX] managed to generate an average of -$212,773 per employee.ADiTx Therapeutics Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 9.00 and a Current Ratio set at 9.00.
An analysis of insider ownership at ADiTx Therapeutics Inc. [ADTX]
There are presently around $1 million, or 6.80% of ADTX stock, in the hands of institutional investors. The top three institutional holders of ADTX stocks are: MORGAN STANLEY with ownership of 122,167, which is approximately New of the company’s market cap and around 6.10% of the total institutional ownership; CREDIT SUISSE AG/, holding 51,912 shares of the stock with an approximate value of $0.17 million in ADTX stocks shares; and VIRTU FINANCIAL LLC, currently with $52000.0 in ADTX stock with ownership of nearly New of the company’s market capitalization.
Positions in ADiTx Therapeutics Inc. stocks held by institutional investors increased at the end of June and at the time of the June reporting period, where 9 institutional holders increased their position in ADiTx Therapeutics Inc. [NASDAQ:ADTX] by around 203,911 shares. Additionally, 4 investors decreased positions by around 240,609 shares, while 2 investors held positions by with 220,689 shares. The mentioned changes placed institutional holdings at 223,831 shares, according to the latest SEC report filing. ADTX stock had 7 new institutional investments in for a total of 203,801 shares, while 3 institutional investors sold positions of 226,368 shares during the same period.